Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Assay Kit / ADA/PK Assay Elisa Kit

Selicrelumab ELISA Kit

Catalog #:   KDD68907 Specific References (24) DATASHEET
Sample type: Plasma, Serum
Sensitivity: 33.12 ng/mL
Range: 78.125 - 5,000 ng/mL
Overview

Catalog No.

KDD68907

Detection method

Colorimetric

Sample type

Plasma, Serum

Assay type

Quantitative

Range

78.125 - 5,000 ng/mL

Sensitivity

33.12 ng/mL

Precision

CV<20%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Alternative Names

CAS: 1622140-49-1

Data Image
References

Systemic immune response to a CD40 agonist antibody in nonhuman primates., PMID:38372596

Harnessing the potential of CD40 agonism in cancer therapy., PMID:38102001

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia., PMID:34205588

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer., PMID:34112709

TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy., PMID:34101617

Agonistic CD40 Antibodies in Cancer Treatment., PMID:33804039

Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients., PMID:33097612

New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)., PMID:31275618

Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters., PMID:28619093

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma., PMID:26386124

Dual Immunotherapies Shrink Melanomas., PMID:25998399

Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma., PMID:25252722

Harnessing immune responses in the tumor microenvironment: all signals needed., PMID:24097857

A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma., PMID:23983255

Immunotherapy of cancer in 2012., PMID:22576456

CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome., PMID:22459705

The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice., PMID:21479995

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans., PMID:21436454

Poking CD40 for cancer therapy, another example of the Goldilocks effect., PMID:21057206

Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors., PMID:20855968

CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893., PMID:20842056

Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation., PMID:19906293

An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model., PMID:17444959

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody., PMID:17327609

Datasheet

Document Download

Selicrelumab ELISA Kit.pdf

 

$ 1128
Product specifications
96 T 1128

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Selicrelumab ELISA Kit [KDD68907]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only